Page 36 - C:\Users\MY PC\Desktop\FlipBook
P. 36

38



















                                                        =












             Each component of                                      , have demonstrated the

             benefits of cardiovascular risk reduction.














                                     45%



                                                                      ARB/CCB










             Among initial combination therapy users, the most frequently
             continued combination therapy was ARB/CCB.












             Eur J Prev Cardiol. 2020: 6;2047487319900326, J Clin Hypertens. 2008;10: supp.1
   31   32   33   34   35   36   37   38   39   40   41